| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone binding | 2.53e-04 | 265 | 43 | 5 | GO:0042393 | |
| GeneOntologyCellularComponent | nuclear body | SART3 HABP4 CHD3 RBM25 PCGF2 EIF4ENIF1 ATRX HECTD1 THRAP3 ATF7IP ZC3H13 | 1.49e-06 | 903 | 43 | 11 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear speck | 2.56e-05 | 431 | 43 | 7 | GO:0016607 | |
| HumanPheno | Widely-spaced maxillary central incisors | 1.19e-06 | 10 | 12 | 3 | HP:0001566 | |
| HumanPheno | Central incisor gap | 2.82e-06 | 13 | 12 | 3 | HP:0001570 | |
| HumanPheno | Widely-spaced incisors | 2.82e-06 | 13 | 12 | 3 | HP:0006304 | |
| HumanPheno | Abnormal spaced incisors | 3.58e-06 | 14 | 12 | 3 | HP:0040159 | |
| HumanPheno | Misalignment of incisors | 5.50e-06 | 16 | 12 | 3 | HP:0011062 | |
| HumanPheno | Diastema | 2.52e-05 | 26 | 12 | 3 | HP:0000699 | |
| HumanPheno | Hyperactivity | 8.82e-05 | 558 | 12 | 7 | HP:0000752 | |
| HumanPheno | Abnormal response to social norms | 1.05e-04 | 807 | 12 | 8 | HP:5200123 | |
| HumanPheno | Social disinhibition | 1.05e-04 | 807 | 12 | 8 | HP:5200029 | |
| HumanPheno | Disinhibition | 1.05e-04 | 807 | 12 | 8 | HP:0000734 | |
| HumanPheno | Inappropriate behavior | 1.05e-04 | 807 | 12 | 8 | HP:0000719 | |
| HumanPheno | Impairment in personality functioning | 1.56e-04 | 1141 | 12 | 9 | HP:0031466 | |
| HumanPheno | Abnormally increased volition | 1.80e-04 | 869 | 12 | 8 | HP:5200263 | |
| HumanPheno | Thin vermilion border | 2.16e-04 | 433 | 12 | 6 | HP:0000233 | |
| HumanPheno | Abnormal social development | 2.49e-04 | 908 | 12 | 8 | HP:0025732 | |
| HumanPheno | Abnormality of upper lip vermillion | 3.17e-04 | 464 | 12 | 6 | HP:0011339 | |
| HumanPheno | Abnormal volitional state | 3.60e-04 | 1263 | 12 | 9 | HP:0025780 | |
| HumanPheno | Abnormal motivation | 3.60e-04 | 1263 | 12 | 9 | HP:5200275 | |
| HumanPheno | Aplasia/Hypoplasia affecting the fundus | 3.87e-04 | 965 | 12 | 8 | HP:0008057 | |
| HumanPheno | Aplasia/Hypoplasia of the optic nerve | 3.94e-04 | 704 | 12 | 7 | HP:0008058 | |
| HumanPheno | Recurrent maladaptive behavior | 4.36e-04 | 1293 | 12 | 9 | HP:5200241 | |
| HumanPheno | Reduced impulse control | 6.27e-04 | 1032 | 12 | 8 | HP:5200045 | |
| HumanPheno | Thin upper lip vermilion | 6.80e-04 | 339 | 12 | 5 | HP:0000219 | |
| HumanPheno | Thin lips | 6.80e-04 | 339 | 12 | 5 | HP:0000213 | |
| HumanPheno | Paraganglioma | 8.51e-04 | 19 | 12 | 2 | HP:0002668 | |
| Domain | Znf_FYVE_PHD | 1.90e-05 | 147 | 42 | 5 | IPR011011 | |
| Domain | ADD | 2.95e-05 | 4 | 42 | 2 | IPR025766 | |
| Domain | ADD | 2.95e-05 | 4 | 42 | 2 | PS51533 | |
| Domain | ZF_PHD_2 | 6.06e-05 | 95 | 42 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 6.32e-05 | 96 | 42 | 4 | PS01359 | |
| Domain | Zinc_finger_PHD-type_CS | 4.19e-04 | 65 | 42 | 3 | IPR019786 | |
| Domain | PHD | 6.38e-04 | 75 | 42 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 7.42e-04 | 79 | 42 | 3 | IPR019787 | |
| Domain | PHD | 1.05e-03 | 89 | 42 | 3 | SM00249 | |
| Domain | Znf_PHD | 1.12e-03 | 91 | 42 | 3 | IPR001965 | |
| Domain | HECT | 1.67e-03 | 27 | 42 | 2 | PF00632 | |
| Domain | HECTc | 1.67e-03 | 27 | 42 | 2 | SM00119 | |
| Domain | HECT_dom | 1.67e-03 | 27 | 42 | 2 | IPR000569 | |
| Domain | HECT | 1.67e-03 | 27 | 42 | 2 | PS50237 | |
| Domain | SNF2_N | 2.35e-03 | 32 | 42 | 2 | IPR000330 | |
| Domain | SNF2_N | 2.35e-03 | 32 | 42 | 2 | PF00176 | |
| Domain | - | 3.21e-03 | 449 | 42 | 5 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 3.53e-03 | 459 | 42 | 5 | IPR013083 | |
| Domain | - | 5.43e-03 | 49 | 42 | 2 | 1.20.80.10 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 5.65e-03 | 50 | 42 | 2 | IPR014352 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 1.17e-04 | 41 | 33 | 3 | MM15630 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 1.26e-04 | 42 | 33 | 3 | M41821 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ANKRD11 SART3 DIDO1 PHF14 CHD3 CLINT1 RBM25 ATRX ZNF512 THRAP3 ATF7IP ZC3H13 | 1.59e-09 | 954 | 44 | 12 | 36373674 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KIAA1671 ANKRD11 CACNA1C PHF14 CHD3 HUWE1 ATRX ZNF512 HECTD1 THRAP3 FARP1 KRCC1 | 2.14e-07 | 1489 | 44 | 12 | 28611215 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.51e-07 | 774 | 44 | 9 | 15302935 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 8.38e-07 | 256 | 44 | 6 | 33397691 | |
| Pubmed | KIAA1671 DIDO1 CHD3 RBM25 LIN37 EIF4ENIF1 ATRX ZNF512 BSG ATF7IP PRDM1 | 1.19e-06 | 1429 | 44 | 11 | 35140242 | |
| Pubmed | 1.45e-06 | 653 | 44 | 8 | 22586326 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.50e-06 | 283 | 44 | 6 | 30585729 | |
| Pubmed | Chronic viral infection alters PD-1 locus subnuclear localization in cytotoxic CD8+ T cells. | 1.56e-06 | 2 | 44 | 2 | 39083377 | |
| Pubmed | 1.66e-06 | 157 | 44 | 5 | 30186101 | ||
| Pubmed | ANKRD11 SART3 SLC4A7 ATRX ZNF512 ANKRD52 BSG ESYT1 FARP1 ZC3H13 MRPL48 | 1.75e-06 | 1487 | 44 | 11 | 33957083 | |
| Pubmed | KIAA1671 ANKRD11 SART3 DIDO1 PHF14 HABP4 SLC4A7 EIF4ENIF1 ATRX ESYT1 FARP1 | 1.87e-06 | 1497 | 44 | 11 | 31527615 | |
| Pubmed | 3.06e-06 | 503 | 44 | 7 | 16964243 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 12505151 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 8.60e-06 | 220 | 44 | 5 | 35785414 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 CLINT1 RBM25 HUWE1 ATRX ZNF512 BSG THRAP3 ESYT1 ANP32A | 8.97e-06 | 1425 | 44 | 10 | 30948266 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 9.98e-06 | 394 | 44 | 6 | 27248496 | |
| Pubmed | 1.05e-05 | 608 | 44 | 7 | 16713569 | ||
| Pubmed | 1.07e-05 | 399 | 44 | 6 | 37536630 | ||
| Pubmed | 1.40e-05 | 418 | 44 | 6 | 34709266 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 1.47e-05 | 422 | 44 | 6 | 27342126 | |
| Pubmed | 1.53e-05 | 425 | 44 | 6 | 24999758 | ||
| Pubmed | 1.55e-05 | 38 | 44 | 3 | 28680062 | ||
| Pubmed | 1.56e-05 | 5 | 44 | 2 | 28425671 | ||
| Pubmed | 1.75e-05 | 255 | 44 | 5 | 15324660 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.97e-05 | 934 | 44 | 8 | 33916271 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 2.31e-05 | 1257 | 44 | 9 | 36526897 | |
| Pubmed | 2.34e-05 | 6 | 44 | 2 | 24100041 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.34e-05 | 271 | 44 | 5 | 32433965 | |
| Pubmed | 2.46e-05 | 133 | 44 | 4 | 15144186 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 2.91e-05 | 1294 | 44 | 9 | 30804502 | |
| Pubmed | 3.27e-05 | 7 | 44 | 2 | 23362347 | ||
| Pubmed | 3.54e-05 | 1327 | 44 | 9 | 32694731 | ||
| Pubmed | 3.54e-05 | 1014 | 44 | 8 | 32416067 | ||
| Pubmed | 4.56e-05 | 1371 | 44 | 9 | 36244648 | ||
| Pubmed | 5.05e-05 | 777 | 44 | 7 | 35844135 | ||
| Pubmed | MicroRNA and target gene expression based clustering of oral cancer, precancer and normal tissues. | 5.60e-05 | 9 | 44 | 2 | 27515006 | |
| Pubmed | 5.67e-05 | 1084 | 44 | 8 | 11544199 | ||
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 5.90e-05 | 329 | 44 | 5 | 34316702 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 5.98e-05 | 330 | 44 | 5 | 33301849 | |
| Pubmed | 6.15e-05 | 332 | 44 | 5 | 37433992 | ||
| Pubmed | 6.15e-05 | 332 | 44 | 5 | 25693804 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 6.15e-05 | 332 | 44 | 5 | 32786267 | |
| Pubmed | 6.26e-05 | 547 | 44 | 6 | 37267103 | ||
| Pubmed | 6.39e-05 | 549 | 44 | 6 | 38280479 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 6.40e-05 | 807 | 44 | 7 | 22681889 | |
| Pubmed | 6.99e-05 | 10 | 44 | 2 | 36635505 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 7.48e-05 | 565 | 44 | 6 | 25468996 | |
| Pubmed | 8.02e-05 | 1139 | 44 | 8 | 36417873 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 8.78e-05 | 358 | 44 | 5 | 32460013 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 9.05e-05 | 853 | 44 | 7 | 28718761 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 9.31e-05 | 588 | 44 | 6 | 38580884 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 9.32e-05 | 857 | 44 | 7 | 25609649 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 9.59e-05 | 861 | 44 | 7 | 36931259 | |
| Pubmed | 1.02e-04 | 12 | 44 | 2 | 30759395 | ||
| Pubmed | PAQR9 Modulates BAG6-mediated protein quality control of mislocalized membrane proteins. | 1.02e-04 | 12 | 44 | 2 | 31904842 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.09e-04 | 605 | 44 | 6 | 28977666 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.12e-04 | 608 | 44 | 6 | 36089195 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.12e-04 | 377 | 44 | 5 | 38117590 | |
| Pubmed | 1.41e-04 | 916 | 44 | 7 | 32203420 | ||
| Pubmed | 1.41e-04 | 14 | 44 | 2 | 16455055 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 1.47e-04 | 922 | 44 | 7 | 27609421 | |
| Pubmed | Regulation of ubiquitin-proteasome system-mediated Tip110 protein degradation by USP15. | 1.86e-04 | 16 | 44 | 2 | 24984263 | |
| Pubmed | 1.86e-04 | 87 | 44 | 3 | 29991678 | ||
| Pubmed | 2.10e-04 | 17 | 44 | 2 | 29299163 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 2.12e-04 | 232 | 44 | 4 | 25515538 | |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 2.19e-04 | 92 | 44 | 3 | 15840729 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 2.25e-04 | 989 | 44 | 7 | 36424410 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.29e-04 | 440 | 44 | 5 | 34244565 | |
| Pubmed | 2.36e-04 | 18 | 44 | 2 | 25569111 | ||
| Pubmed | 2.38e-04 | 239 | 44 | 4 | 26641092 | ||
| Pubmed | 2.44e-04 | 446 | 44 | 5 | 24255178 | ||
| Pubmed | 2.51e-04 | 1007 | 44 | 7 | 34597346 | ||
| Pubmed | 2.52e-04 | 449 | 44 | 5 | 31732153 | ||
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | 2.70e-04 | 247 | 44 | 4 | 32989298 | |
| Pubmed | 2.80e-04 | 100 | 44 | 3 | 10048485 | ||
| Pubmed | 2.87e-04 | 251 | 44 | 4 | 28077445 | ||
| Pubmed | 3.22e-04 | 1049 | 44 | 7 | 27880917 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 3.32e-04 | 477 | 44 | 5 | 31300519 | |
| Pubmed | Identification of an FMNL2 Interactome by Quantitative Mass Spectrometry. | 3.33e-04 | 106 | 44 | 3 | 38891874 | |
| Pubmed | 3.62e-04 | 267 | 44 | 4 | 33417871 | ||
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 3.72e-04 | 269 | 44 | 4 | 29511261 | |
| Pubmed | 3.86e-04 | 493 | 44 | 5 | 15368895 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 3.88e-04 | 1082 | 44 | 7 | 38697112 | |
| Pubmed | 3.97e-04 | 1440 | 44 | 8 | 30833792 | ||
| Pubmed | 4.01e-04 | 1442 | 44 | 8 | 35575683 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 4.04e-04 | 498 | 44 | 5 | 36634849 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 4.40e-04 | 1105 | 44 | 7 | 35748872 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 4.88e-04 | 289 | 44 | 4 | 23752268 | |
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 4.99e-04 | 26 | 44 | 2 | 26949039 | |
| Pubmed | 5.13e-04 | 808 | 44 | 6 | 20412781 | ||
| Pubmed | 5.14e-04 | 123 | 44 | 3 | 35583604 | ||
| Pubmed | 5.47e-04 | 298 | 44 | 4 | 30737378 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 5.50e-04 | 533 | 44 | 5 | 30554943 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 6.04e-04 | 130 | 44 | 3 | 35545047 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 6.88e-04 | 560 | 44 | 5 | 21653829 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 7.50e-04 | 571 | 44 | 5 | 37167062 | |
| Pubmed | 8.06e-04 | 33 | 44 | 2 | 26296893 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 8.17e-04 | 582 | 44 | 5 | 20467437 | |
| Pubmed | 8.29e-04 | 145 | 44 | 3 | 28846114 | ||
| Pubmed | 8.95e-04 | 340 | 44 | 4 | 24332808 | ||
| Interaction | SSRP1 interactions | ANKRD11 DIDO1 ROBO2 PHF14 CHD3 HUWE1 ATRX ZNF512 HECTD1 BSG THRAP3 ZC3H13 ANP32A | 1.42e-09 | 685 | 44 | 13 | int:SSRP1 |
| Interaction | SMC5 interactions | ANKRD11 SART3 DIDO1 PHF14 CHD3 CLINT1 RBM25 ATRX ZNF512 HECTD1 THRAP3 ATF7IP ZC3H13 | 1.26e-07 | 1000 | 44 | 13 | int:SMC5 |
| Interaction | H2BC21 interactions | SART3 DIDO1 PHF14 ARHGAP30 PCGF2 HUWE1 ATRX ZNF512 MRPL48 ANP32A | 1.94e-06 | 696 | 44 | 10 | int:H2BC21 |
| Interaction | CENPU interactions | 4.62e-06 | 113 | 44 | 5 | int:CENPU | |
| Interaction | MACROH2A1 interactions | 5.79e-06 | 458 | 44 | 8 | int:MACROH2A1 | |
| Interaction | NUCKS1 interactions | 7.89e-06 | 220 | 44 | 6 | int:NUCKS1 | |
| Interaction | BMI1 interactions | 1.03e-05 | 659 | 44 | 9 | int:BMI1 | |
| Interaction | IFI27L1 interactions | 1.21e-05 | 65 | 44 | 4 | int:IFI27L1 | |
| Interaction | CENPA interactions | 1.60e-05 | 377 | 44 | 7 | int:CENPA | |
| Interaction | CHD3 interactions | 3.09e-05 | 757 | 44 | 9 | int:CHD3 | |
| Interaction | CBX1 interactions | 3.62e-05 | 288 | 44 | 6 | int:CBX1 | |
| Interaction | PRPF3 interactions | 3.83e-05 | 291 | 44 | 6 | int:PRPF3 | |
| Interaction | LSM4 interactions | 4.17e-05 | 178 | 44 | 5 | int:LSM4 | |
| Interaction | PEA15 interactions | 4.40e-05 | 90 | 44 | 4 | int:PEA15 | |
| Interaction | GAGE2E interactions | 6.59e-05 | 36 | 44 | 3 | int:GAGE2E | |
| Interaction | PCGF5 interactions | 6.92e-05 | 101 | 44 | 4 | int:PCGF5 | |
| Interaction | U2AF2 interactions | 7.20e-05 | 651 | 44 | 8 | int:U2AF2 | |
| Interaction | UHRF2 interactions | 7.26e-05 | 200 | 44 | 5 | int:UHRF2 | |
| Interaction | PHLPP1 interactions | 8.09e-05 | 333 | 44 | 6 | int:PHLPP1 | |
| Interaction | POLR1G interactions | 8.35e-05 | 489 | 44 | 7 | int:POLR1G | |
| Interaction | RNF2 interactions | 8.76e-05 | 866 | 44 | 9 | int:RNF2 | |
| Interaction | DEK interactions | 8.94e-05 | 209 | 44 | 5 | int:DEK | |
| Interaction | ANKRD50 interactions | 8.98e-05 | 108 | 44 | 4 | int:ANKRD50 | |
| Interaction | SETDB1 interactions | 9.99e-05 | 214 | 44 | 5 | int:SETDB1 | |
| Interaction | SNRPB interactions | 1.18e-04 | 517 | 44 | 7 | int:SNRPB | |
| Interaction | EWSR1 interactions | 1.24e-04 | 906 | 44 | 9 | int:EWSR1 | |
| Interaction | GATAD2A interactions | 1.24e-04 | 224 | 44 | 5 | int:GATAD2A | |
| Interaction | MOB3C interactions | 1.32e-04 | 364 | 44 | 6 | int:MOB3C | |
| Interaction | MYCN interactions | SART3 DIDO1 HABP4 HUWE1 ZNF512 THRAP3 FARP1 ZC3H13 MRPL48 GRK1 DNMT3A | 1.33e-04 | 1373 | 44 | 11 | int:MYCN |
| Interaction | XRCC6 interactions | 1.48e-04 | 928 | 44 | 9 | int:XRCC6 | |
| Interaction | DDOST interactions | 1.55e-04 | 375 | 44 | 6 | int:DDOST | |
| Interaction | B3GAT1 interactions | 1.59e-04 | 377 | 44 | 6 | int:B3GAT1 | |
| Interaction | MEX3A interactions | 1.76e-04 | 384 | 44 | 6 | int:MEX3A | |
| Interaction | KIF2A interactions | 1.78e-04 | 242 | 44 | 5 | int:KIF2A | |
| Interaction | TNIP2 interactions | KIAA1671 ANKRD11 SART3 CACNA1C PHF14 THRAP3 ATF7IP ZC3H13 ANP32A | 1.80e-04 | 952 | 44 | 9 | int:TNIP2 |
| Interaction | SIRT7 interactions | 1.81e-04 | 744 | 44 | 8 | int:SIRT7 | |
| Interaction | GAGE5 interactions | 1.99e-04 | 52 | 44 | 3 | int:GAGE5 | |
| Interaction | EED interactions | DIDO1 CHD3 CLINT1 RBM25 LIN37 PCGF2 HUWE1 HECTD1 THRAP3 ZC3H13 DNMT3A | 2.09e-04 | 1445 | 44 | 11 | int:EED |
| Interaction | SRSF1 interactions | 2.16e-04 | 570 | 44 | 7 | int:SRSF1 | |
| Interaction | UPF3B interactions | 2.18e-04 | 136 | 44 | 4 | int:UPF3B | |
| Interaction | NAA40 interactions | 2.20e-04 | 978 | 44 | 9 | int:NAA40 | |
| Interaction | IFI6 interactions | 2.23e-04 | 54 | 44 | 3 | int:IFI6 | |
| Interaction | CDH1 interactions | 2.25e-04 | 768 | 44 | 8 | int:CDH1 | |
| Interaction | PAQR9 interactions | 2.53e-04 | 11 | 44 | 2 | int:PAQR9 | |
| Interaction | DIRAS3 interactions | 2.57e-04 | 262 | 44 | 5 | int:DIRAS3 | |
| Interaction | IQGAP1 interactions | 2.69e-04 | 591 | 44 | 7 | int:IQGAP1 | |
| Interaction | SMC1A interactions | 2.78e-04 | 418 | 44 | 6 | int:SMC1A | |
| Interaction | YWHAG interactions | KIAA1671 ANKRD11 KLC2 CLINT1 SLC4A7 HUWE1 HECTD1 THRAP3 ESYT1 ZC3H13 | 2.86e-04 | 1248 | 44 | 10 | int:YWHAG |
| Interaction | SRSF7 interactions | 3.04e-04 | 425 | 44 | 6 | int:SRSF7 | |
| Interaction | RNPS1 interactions | 3.04e-04 | 425 | 44 | 6 | int:RNPS1 | |
| Interaction | LMNB1 interactions | 3.25e-04 | 610 | 44 | 7 | int:LMNB1 | |
| Interaction | NIFK interactions | 3.28e-04 | 431 | 44 | 6 | int:NIFK | |
| Interaction | APEX1 interactions | ANKRD11 KLC2 SART3 DIDO1 SLC4A7 ZNF512 KHDC4 BSG THRAP3 ANP32A | 3.32e-04 | 1271 | 44 | 10 | int:APEX1 |
| Interaction | BAG2 interactions | 3.66e-04 | 622 | 44 | 7 | int:BAG2 | |
| Interaction | KRT8 interactions | 3.70e-04 | 441 | 44 | 6 | int:KRT8 | |
| Interaction | SUPT16H interactions | 3.75e-04 | 442 | 44 | 6 | int:SUPT16H | |
| Interaction | NUP43 interactions | 3.77e-04 | 625 | 44 | 7 | int:NUP43 | |
| Interaction | CALM1 interactions | 3.80e-04 | 626 | 44 | 7 | int:CALM1 | |
| Interaction | MED4 interactions | 4.12e-04 | 450 | 44 | 6 | int:MED4 | |
| Interaction | DHX8 interactions | 4.22e-04 | 292 | 44 | 5 | int:DHX8 | |
| Interaction | RPA4 interactions | 4.22e-04 | 452 | 44 | 6 | int:RPA4 | |
| Interaction | SNRNP40 interactions | 4.22e-04 | 637 | 44 | 7 | int:SNRNP40 | |
| Interaction | YY1 interactions | 4.32e-04 | 454 | 44 | 6 | int:YY1 | |
| Interaction | PARP1 interactions | DIDO1 PHF14 CHD3 RBM25 PCGF2 HUWE1 ZNF512 HECTD1 THRAP3 DNMT3A | 4.37e-04 | 1316 | 44 | 10 | int:PARP1 |
| Interaction | DNAJC9 interactions | 4.49e-04 | 296 | 44 | 5 | int:DNAJC9 | |
| Interaction | HDLBP interactions | 4.63e-04 | 855 | 44 | 8 | int:HDLBP | |
| Interaction | MYBBP1A interactions | 4.79e-04 | 463 | 44 | 6 | int:MYBBP1A | |
| Interaction | RPS3A interactions | 4.99e-04 | 655 | 44 | 7 | int:RPS3A | |
| Interaction | HDAC2 interactions | 5.00e-04 | 865 | 44 | 8 | int:HDAC2 | |
| Interaction | MCAM interactions | 5.07e-04 | 468 | 44 | 6 | int:MCAM | |
| Interaction | SAP18 interactions | 5.15e-04 | 305 | 44 | 5 | int:SAP18 | |
| Interaction | YWHAH interactions | KIAA1671 ANKRD11 KLC2 CLINT1 SLC4A7 HUWE1 HECTD1 ESYT1 ZC3H13 | 5.29e-04 | 1102 | 44 | 9 | int:YWHAH |
| Interaction | ZFHX4 interactions | 5.43e-04 | 73 | 44 | 3 | int:ZFHX4 | |
| Interaction | HDAC1 interactions | KIAA1671 PHF14 CHD3 RBM25 EIF4ENIF1 ATRX HECTD1 DNMT3A PRDM1 | 5.50e-04 | 1108 | 44 | 9 | int:HDAC1 |
| Interaction | DDX23 interactions | 5.80e-04 | 480 | 44 | 6 | int:DDX23 | |
| Interaction | H2AC8 interactions | 5.94e-04 | 177 | 44 | 4 | int:H2AC8 | |
| Interaction | FXR1 interactions | 6.18e-04 | 679 | 44 | 7 | int:FXR1 | |
| Interaction | ADARB1 interactions | 6.39e-04 | 489 | 44 | 6 | int:ADARB1 | |
| Interaction | H3C1 interactions | 6.54e-04 | 901 | 44 | 8 | int:H3C1 | |
| Interaction | H2BC12 interactions | 6.58e-04 | 322 | 44 | 5 | int:H2BC12 | |
| Interaction | H3C3 interactions | 6.81e-04 | 495 | 44 | 6 | int:H3C3 | |
| Interaction | CFDP1 interactions | 6.84e-04 | 79 | 44 | 3 | int:CFDP1 | |
| Interaction | EIF4A3 interactions | 7.10e-04 | 499 | 44 | 6 | int:EIF4A3 | |
| Interaction | TOP1 interactions | 7.16e-04 | 696 | 44 | 7 | int:TOP1 | |
| Interaction | PSENEN interactions | 7.36e-04 | 81 | 44 | 3 | int:PSENEN | |
| Interaction | ENTR1 interactions | 7.44e-04 | 188 | 44 | 4 | int:ENTR1 | |
| Interaction | KAT6A interactions | 7.96e-04 | 510 | 44 | 6 | int:KAT6A | |
| Interaction | EIF3B interactions | 8.07e-04 | 337 | 44 | 5 | int:EIF3B | |
| Interaction | LZTS2 interactions | 8.12e-04 | 512 | 44 | 6 | int:LZTS2 | |
| Interaction | RPL18 interactions | 8.12e-04 | 512 | 44 | 6 | int:RPL18 | |
| Interaction | ASB3 interactions | 8.18e-04 | 84 | 44 | 3 | int:ASB3 | |
| Interaction | SKA3 interactions | 8.36e-04 | 194 | 44 | 4 | int:SKA3 | |
| Interaction | DDX21 interactions | 8.59e-04 | 718 | 44 | 7 | int:DDX21 | |
| Interaction | MDN1 interactions | 8.69e-04 | 196 | 44 | 4 | int:MDN1 | |
| Interaction | LYN interactions | 8.73e-04 | 720 | 44 | 7 | int:LYN | |
| Interaction | BPTF interactions | 8.86e-04 | 197 | 44 | 4 | int:BPTF | |
| Interaction | SRSF3 interactions | 8.98e-04 | 522 | 44 | 6 | int:SRSF3 | |
| Interaction | CAV1 interactions | 9.02e-04 | 724 | 44 | 7 | int:CAV1 | |
| Interaction | SMC6 interactions | 9.06e-04 | 87 | 44 | 3 | int:SMC6 | |
| Interaction | SPTB interactions | 9.06e-04 | 87 | 44 | 3 | int:SPTB | |
| Cytoband | 2p23 | 1.21e-04 | 17 | 44 | 2 | 2p23 | |
| Cytoband | 16q24.3 | 1.15e-03 | 52 | 44 | 2 | 16q24.3 | |
| GeneFamily | PHD finger proteins | 4.39e-04 | 90 | 30 | 3 | 88 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 5.66e-06 | 417 | 44 | 7 | M39224 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.59e-05 | 90 | 44 | 4 | M39250 | |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 2.05e-05 | 199 | 44 | 5 | M8381 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN | 2.10e-05 | 200 | 44 | 5 | M3893 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ANKRD11 PPP2R2B ARHGAP30 CHD3 SLC4A7 HUWE1 ATRX THRAP3 ESYT1 ATF7IP PRDM1 | 2.63e-05 | 1492 | 44 | 11 | M40023 |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_GRANULOCYTE_AGEING | 3.61e-05 | 224 | 44 | 5 | MM3836 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 9.93e-05 | 1144 | 44 | 9 | MM3843 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.66e-07 | 259 | 44 | 7 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | ANKRD11 DIDO1 ROBO2 RBM25 SLC4A7 ATRX THRAP3 ZC3H13 DNMT3A PRDM1 | 4.51e-06 | 806 | 44 | 10 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 3.29e-05 | 804 | 44 | 9 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_100 | 7.20e-05 | 39 | 44 | 3 | gudmap_developingGonad_e12.5_testes_k1_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.10e-04 | 230 | 44 | 5 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#3_top-relative-expression-ranked_100 | 1.43e-04 | 49 | 44 | 3 | gudmap_developingGonad_e11.5_testes_k3_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_100 | 1.52e-04 | 50 | 44 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k2_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.75e-04 | 780 | 44 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.91e-04 | 790 | 44 | 8 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 2.10e-04 | 801 | 44 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.52e-04 | 275 | 44 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.61e-04 | 277 | 44 | 5 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.70e-04 | 831 | 44 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.93e-04 | 284 | 44 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.62e-04 | 67 | 44 | 3 | gudmap_developingGonad_e12.5_testes_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_200 | 3.75e-04 | 165 | 44 | 4 | gudmap_developingGonad_e12.5_testes_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.90e-04 | 469 | 44 | 6 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_100 | 5.60e-04 | 17 | 44 | 2 | gudmap_developingGonad_e16.5_testes_100_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_100 | 6.56e-04 | 82 | 44 | 3 | gudmap_developingGonad_e12.5_testes_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 7.56e-04 | 532 | 44 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4-.Lv, CD45 TCRb aGalCer-loaded CD1d tet, Liver, avg-4 | 7.67e-04 | 351 | 44 | 5 | GSM538325_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_100 | 7.79e-04 | 87 | 44 | 3 | gudmap_developingGonad_e11.5_testes_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#5_top-relative-expression-ranked_200 | 8.06e-04 | 88 | 44 | 3 | gudmap_developingGonad_e12.5_testes_k5_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_100 | 8.60e-04 | 90 | 44 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.02e-03 | 564 | 44 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-08 | 195 | 44 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-08 | 195 | 44 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 184 | 44 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.15e-06 | 188 | 44 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.18e-06 | 189 | 44 | 5 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.38e-06 | 195 | 44 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.45e-06 | 197 | 44 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.52e-06 | 199 | 44 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.52e-06 | 199 | 44 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.52e-06 | 199 | 44 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.52e-06 | 199 | 44 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-06 | 200 | 44 | 5 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-05 | 161 | 44 | 4 | 580153e131247e6ec12a1a920f050a0a763e7e87 | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 2.97e-05 | 180 | 44 | 4 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 185 | 44 | 4 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 185 | 44 | 4 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.52e-05 | 188 | 44 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.59e-05 | 189 | 44 | 4 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-05 | 190 | 44 | 4 | ce049630ed69d31f00acbc1b5b0896efc592121f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 191 | 44 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 191 | 44 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-05 | 193 | 44 | 4 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 194 | 44 | 4 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 194 | 44 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 3.98e-05 | 194 | 44 | 4 | 4903a0d6e36599bcb83b179462e5b949df9eb685 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 4.14e-05 | 196 | 44 | 4 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 4.14e-05 | 196 | 44 | 4 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 4.14e-05 | 196 | 44 | 4 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 4.22e-05 | 197 | 44 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 4.30e-05 | 198 | 44 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 4.39e-05 | 199 | 44 | 4 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.39e-05 | 199 | 44 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 4.39e-05 | 199 | 44 | 4 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 4.39e-05 | 199 | 44 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.48e-05 | 200 | 44 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Basaloid_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.57e-04 | 106 | 44 | 3 | af3ac319e65f19f2f690a7e9db434c552893c5f1 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.49e-04 | 124 | 44 | 3 | 1483be8700eca7e2c288784a290d945d4022b17f | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.20e-04 | 135 | 44 | 3 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 3.41e-04 | 138 | 44 | 3 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.44e-04 | 151 | 44 | 3 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.88e-04 | 156 | 44 | 3 | fbe23876f0899853cea3c5c4f3044a9cea064d5b | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.25e-04 | 160 | 44 | 3 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.25e-04 | 160 | 44 | 3 | 5c931e859acf67c1c8664941e0e44d195f8ba75b | |
| ToppCell | COVID-19_Severe-Treg|World / disease group, cell group and cell class | 5.35e-04 | 161 | 44 | 3 | c6eade2c60c572d823e6e81b5e8d47078671e9b0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.54e-04 | 163 | 44 | 3 | 1c014e373667be290d7fb5d24c06c6f313ac8fa3 | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.54e-04 | 163 | 44 | 3 | 43887e7687fc6367efac0c1f56a9534b06f47b7f | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.54e-04 | 163 | 44 | 3 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-04 | 164 | 44 | 3 | 9fed5df40f50bde35db8bf89c291cbdc0e104112 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-04 | 164 | 44 | 3 | e712d6b89461f741dbd773ba9a27ecaddf97cbaa | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.74e-04 | 165 | 44 | 3 | 5e7ee76f3dcddbd1b560bacd043f9001b0c18b5f | |
| ToppCell | Adult-Immune-natural_killer_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.95e-04 | 167 | 44 | 3 | ff1ce3b1a2d91d2ad979f25899db4f4eeb865892 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.16e-04 | 169 | 44 | 3 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.16e-04 | 169 | 44 | 3 | 7cb1b87be66a22fe5731bb1b55bc515920fe3e8b | |
| ToppCell | COVID-19_Severe-Treg|COVID-19_Severe / disease group, cell group and cell class | 6.26e-04 | 170 | 44 | 3 | d61269a51283125835884c4aa50623756c4fdda2 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B2|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.37e-04 | 171 | 44 | 3 | d1c5540e59c64eb233acab53bfd0d68e922a74bb | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.37e-04 | 171 | 44 | 3 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 173 | 44 | 3 | 513b4d31bcfb269556c6b4cc389865fb12e52c4f | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 173 | 44 | 3 | e4eb2ac2cee16bfa8eabc938f8030ee161c972c5 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 173 | 44 | 3 | 371515471459307a3b2adce735263b4aac828956 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 173 | 44 | 3 | 4e9b6c71030ae0d63d54e7255e4a10b25970fcc4 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.70e-04 | 174 | 44 | 3 | 33386750842c47ad7e7286d0f26a556da1a2de02 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-04 | 174 | 44 | 3 | 0e541581df2d4249270b28ceded6298329013580 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.70e-04 | 174 | 44 | 3 | 9344d4e76d7d9429aea87d3c0b98246200d16014 | |
| ToppCell | facs-Marrow-T_cells-18m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-04 | 175 | 44 | 3 | d3d574962c0a4a0d64db120320f0d04e11d2c9d8 | |
| ToppCell | facs-Marrow-T_cells|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-04 | 175 | 44 | 3 | 4d77fade9ab87b79ac206d074b0e2ef8930c044e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.81e-04 | 175 | 44 | 3 | f2c3e0f728a43d6988e793c8a50c964f7447db82 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.93e-04 | 176 | 44 | 3 | 7b5e50eb144bf43ca0cf354a466eb58b976a79f1 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-regulatory_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.93e-04 | 176 | 44 | 3 | 856a8c4211ea33d926b18d8959a03909562aa563 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-04 | 176 | 44 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.04e-04 | 177 | 44 | 3 | b326376e879afef579b1b7094d756aaff0de270b | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.04e-04 | 177 | 44 | 3 | 393882f1bf7658a17e10a771b803339f16fb2e69 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-04 | 178 | 44 | 3 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | C_00|World / shred on cell type and cluster | 7.27e-04 | 179 | 44 | 3 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.27e-04 | 179 | 44 | 3 | 593fc323b28304a57ae162f64b0890b893fff446 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.27e-04 | 179 | 44 | 3 | 708fc0b8ffcb5fac43c52541acb6671fe1cfbb0d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.39e-04 | 180 | 44 | 3 | 6bb9f41c3a99d1bbe697f589fb2bcea9b7bfbeee | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.51e-04 | 181 | 44 | 3 | 12ff56fa2949c8d53360cdf2cacfd326e65b54aa | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R+_NK_cell|World / Lineage, cell class and subclass | 7.51e-04 | 181 | 44 | 3 | 0d096d7d557fd2e71b35e41816e11d7e83cd9210 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.63e-04 | 182 | 44 | 3 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | CTRL-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 7.63e-04 | 182 | 44 | 3 | ee137574b8f0e684a4a7cb26226877c471cae433 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-04 | 182 | 44 | 3 | df26388c0c46d1c4775103c8e802937b4d4e7470 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-04 | 183 | 44 | 3 | 062ec08d66c923f90fee771b1bf8d98bdc7e6c1b | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.88e-04 | 184 | 44 | 3 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.00e-04 | 185 | 44 | 3 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.13e-04 | 186 | 44 | 3 | 8ea708070166c858cd9bd871670655b0114c32a5 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.25e-04 | 187 | 44 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 8.25e-04 | 187 | 44 | 3 | 4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 8.25e-04 | 187 | 44 | 3 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R+_NK_cell|lymphoid / Lineage, cell class and subclass | 8.25e-04 | 187 | 44 | 3 | 99dfa50f6325b0d66d23ee8dcaa6437e7161628a | |
| ToppCell | ILEUM-inflamed-(1)_CD8_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.25e-04 | 187 | 44 | 3 | a77d7ae44f47410bd92fb3aa0f44dce891752b63 | |
| ToppCell | COVID-19-kidney-T-cells-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.38e-04 | 188 | 44 | 3 | 15484c05cb496cd98ed3f79a6134c5cec8f09a4d | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-04 | 188 | 44 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-04 | 189 | 44 | 3 | 159b0979c93b7d98aaeeb43fba5983a9f67b9c9d | |
| ToppCell | Control-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 8.51e-04 | 189 | 44 | 3 | ee4c1d930534788a7759d92dc8ff9c62e6ee2301 | |
| ToppCell | (1)_T_CD8_gd|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 8.51e-04 | 189 | 44 | 3 | 62eda4bcfd21d5025ac676d524994ede22721c1d | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.64e-04 | 190 | 44 | 3 | b9182c84e44aa31684b5388cf3ef4fd1b9e51de4 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.64e-04 | 190 | 44 | 3 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.64e-04 | 190 | 44 | 3 | 88c092a5e78ccaddf406f8fff74376bb761b9790 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.64e-04 | 190 | 44 | 3 | 4b42a16902d7d1494f953cc88af1e761e76bdf2c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.64e-04 | 190 | 44 | 3 | 9501f0995f3d52be90c02b1aa0c7d184bd788c16 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.31e-04 | 49 | 30 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.52e-04 | 50 | 30 | 3 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Computational | Neighborhood of DFFA | 4.26e-04 | 129 | 30 | 4 | GCM_DFFA | |
| Computational | Neighborhood of DDB1 | 5.38e-04 | 246 | 30 | 5 | MORF_DDB1 | |
| Computational | Neighborhood of TPR | 6.98e-04 | 147 | 30 | 4 | MORF_TPR | |
| Computational | Neighborhood of HBP1 | 9.47e-04 | 70 | 30 | 3 | GCM_HBP1 | |
| Disease | cancer | 2.81e-04 | 400 | 43 | 5 | MONDO_0004992 | |
| Disease | Sezary Syndrome | 7.11e-04 | 27 | 43 | 2 | C0036920 | |
| Disease | lung squamous cell carcinoma (is_marker_for) | 1.27e-03 | 36 | 43 | 2 | DOID:3907 (is_marker_for) | |
| Disease | Growth Disorders | 1.27e-03 | 36 | 43 | 2 | C0018273 | |
| Disease | lung cancer (is_marker_for) | 1.49e-03 | 39 | 43 | 2 | DOID:1324 (is_marker_for) | |
| Disease | prostate specific antigen measurement | 2.60e-03 | 188 | 43 | 3 | EFO_0004624 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVFDKDPDKDDFLGR | 401 | Q9BSJ8 | |
| SERDKRPEGYNLKDE | 121 | Q00005 | |
| ESCKERRDGRAKPEE | 956 | Q6UB99 | |
| EDRKDGEEQEEPRGK | 21 | Q9Y6K1 | |
| KGERFKDVRNPEAEE | 256 | Q9H467 | |
| EERGQKRKREPEDEG | 231 | P39687 | |
| EEDEPLKESRRKEAF | 516 | Q8NB46 | |
| RDRTNEVFKDDEEPK | 1211 | Q9UKP4 | |
| NKFEDEDSDDVPRKR | 696 | P49756 | |
| DRERLDEEAGKTPSD | 36 | Q96GY3 | |
| RRGRSPKGEFKDEEE | 241 | Q14677 | |
| ADPRKKTGFAEDDRK | 1316 | Q9BY89 | |
| KLDDGDDKVFRRAPS | 1106 | O75335 | |
| HERKDKRSTPEEEGR | 151 | A8MQB3 | |
| KFPDEKPGDRFDRDR | 166 | Q5JVS0 | |
| PEESRDGKKDKEGDR | 2036 | Q7Z6Z7 | |
| GRKRSFVPEEEKHEE | 831 | O94880 | |
| EEREESKDKRRDSAP | 416 | Q9H0B6 | |
| RKRRFPFIGEDDNDD | 16 | Q6MZM9 | |
| EFYEGARDRDEKKGP | 136 | P35227 | |
| EDKDDFKGPEFRSRS | 136 | P46100 | |
| RDEDGKTPLDKARER | 456 | Q9ULT8 | |
| EEDKRDIRQSPKRGF | 1956 | Q13936 | |
| DDEDEGRRKRFPTDK | 526 | Q9Y4F1 | |
| DEDFDERPEGRRQSK | 1371 | Q12873 | |
| EKRRKPEDVLDDDDA | 346 | P35613 | |
| QFEERKDPHGEKREF | 1841 | Q9BTC0 | |
| AEDVRKLKARPDDGE | 11 | Q8N6N7 | |
| DDERPSEKNEFSRRK | 541 | Q6VMQ6 | |
| KRRFTEELPDERESG | 461 | Q7Z7F0 | |
| KRHPEEGREKSEEER | 161 | Q9NPI7 | |
| LEKDPEKRLGFRDET | 431 | Q15835 | |
| KIRGPEKRGADEDDE | 616 | Q15020 | |
| ETKRKLPRGAEDRED | 301 | Q7Z6I6 | |
| RKDKESDKEDGRESP | 71 | Q9Y6M7 | |
| EEDFKGRFKARPELE | 191 | Q96GC5 | |
| SEKDLDDFRRRGSPE | 276 | O75626 | |
| SKGKAPEEDEEERRR | 116 | Q9UQ90 | |
| ERDFKDKRFRREFGD | 186 | Q9NRA8 | |
| EEESFPERSKKEDRG | 491 | Q9Y2W1 | |
| KDGERVETDKDDPRS | 66 | Q9HCK4 | |
| PEEERGERSAEEKGR | 221 | Q9Y5U5 | |
| GKRKPRQEEDEDYRE | 101 | Q96ME7 | |
| EEKTRDGKDRGRDFE | 291 | Q5T200 |